Siegel RL, Miller KD, Fuchs HE (2022) A. Jemal. Cancer statistics, CA-CANCER J CLIN 2022;72(1):7–33. doi: 10.3322/caac.21708 pmid:35020204.[(c) 2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.:*2022-01-01]
Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA-CANCER J CLIN 71(3):209–249. https://doi.org/10.3322/caac.21660pmid:33538338.[(c) 2021 American Cancer Society.:*2021-05-01]
Article CAS PubMed Google Scholar
Aronson D, Brenner B (2018) Arterial thrombosis and cancer. THROMB RES 164(Suppl 1):S23–28. https://doi.org/10.1016/j.thromres.2018.01.003. pmid:29703480.[Copyright (c) 2018. Published by Elsevier Ltd.:*2018-04-01]
Article CAS PubMed Google Scholar
Tuzovic M, Herrmann J, Iliescu C et al (2018) Arterial thrombosis in patients with Cancer. Curr Treat Options Cardiovasc Med 20(5):40. https://doi.org/10.1007/s11936-018-0635-xpmid:296278702018-04-07]
Article PubMed PubMed Central Google Scholar
Donnellan E (2017) Khorana. Cancer and venous thromboembolic disease. Rev ONCOLOGIST 22(2):199–207. https://doi.org/10.1634/theoncologist.2016-0214pmid:28174293.[(c) AlphaMed Press 2017.:*2017-02-01]
Connolly GC, Dalal M, Lin J, Khorana AA (2012) Incidence and predictors of venous thromboembolism (VTE) among ambulatory patients with lung cancer. LUNG CANCER.;78(3):253– 58. doi: 10.1016/j.lungcan.2012.09.007 pmid:23026639.[Copyright (c) 2012 Elsevier Ireland Ltd. All rights reserved.:*2012-12-01]
Chew HK, Wun T, Harvey DJ, Zhou H, White RH (2007) Incidence of venous thromboembolism and the impact on survival in breast cancer patients. J CLIN ONCOL 25(1):70–76. https://doi.org/10.1200/JCO.2006.07.4393pmid:171949062007-01-01]
Ziegler S, Sperr WR, Knobl P et al (2005) Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis. THROMB RES.;115(1–2):59–64. https://doi.org/10.1016/j.thromres.2004.07.016 pmid:155674542005-01-20]
Grilz E, Konigsbrugge O, Posch F et al (2018) Frequency, risk factors, and impact on mortality of arterial thromboembolism in patients with cancer. Haematologica 103(9):1549–1556. https://doi.org/10.3324/haematol.2018.192419. pmid:29794142.[Copyright(c) 2018 Ferrata Storti Foundation.:*2018-09-01]
Article PubMed PubMed Central Google Scholar
Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ-BRIT MED J 327(7414):557–560. https://doi.org/10.1136/bmj.327.7414.557pmid:129581202003-09-06]
Egger M, Davey SG, Schneider M (1997) Minder. Bias in meta-analysis detected by a simple, graphical test. BMJ-BRIT MED J 315(7109):629–634. https://doi.org/10.1136/bmj.315.7109.629pmid:93105631997-09-13]
Gervaso L, Dave H, Khorana AA (2021) Venous and arterial thromboembolism in patients with cancer: JACC: cardiooncology State-of-the-Art review. JACC-CARDIOONCOL 3(2):173–190. https://doi.org/10.1016/j.jaccao.2021.03.001pmid:34396323.[(c) 2021 The Authors.:*2021-06-01]
Article PubMed PubMed Central Google Scholar
Kristinsson SY, Pfeiffer RM, Bjorkholm M et al (2010) Arterial and venous thrombosis in monoclonal gammopathy of undetermined significance and multiple myeloma: a population-based study. Blood 115(24):4991–4998. https://doi.org/10.1182/blood-2009-11-252072pmid:202995132010-06-17]
Article CAS PubMed PubMed Central Google Scholar
Navi BB, Reiner AS, Kamel H et al (2017) Risk of arterial thromboembolism in patients with Cancer. J AM COLL CARDIOL 70(8):926–938. https://doi.org/10.1016/j.jacc.2017.06.047. pmid:28818202.[Copyright (c) 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.:*2017-08-22]
Article PubMed PubMed Central Google Scholar
Alex J, Walker TR, Card J, West C, Crooks MJ, Grainge (2012) Incidence of venous thromboembolism in patients with cancer – A cohort study using linked united Kingdom databases. Eur J cancer (1990) 49(6):1404–1413. https://doi.org/10.1016/j.ejca.2012.10.021.[Elsevier Ltd:*
Caine GJ, Stonelake PS, Lip GY, Kehoe ST (2002) The hypercoagulable state of malignancy: pathogenesis and current debate. NEOPLASIA 4(6):465–473. https://doi.org/10.1038/sj.neo.7900263pmid:124074392002-11-01]
Article CAS PubMed PubMed Central Google Scholar
Blann AD, Dunmore S (2011) Arterial and venous thrombosis in cancer patients. CARDIOL RES PRACT 2011:394740. https://doi.org/10.4061/2011/394740. pmid:214038762011-03-03
Article PubMed PubMed Central Google Scholar
Demers M (2014) Wagner. NETosis: a new factor in tumor progression and cancer-associated thrombosis. SEMIN THROMB HEMOST 40(3):277–283. https://doi.org/10.1055/s-0034-1370765pmid:24590420.[Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.:*2014-04-01]
Article CAS PubMed PubMed Central Google Scholar
Connolly GC, Francis CW Cancer-associated thrombosis. HEMATOL-AM SOC HEMAT 2013;2013:684– 91. https://doi.org/10.1182/asheducation-2013.1.684pmid:243192532013-01-20]
Mukai M (2018) Toru Oka. Mechanism and management of cancer-associated thrombosis. J CARDIOL 72(2):89–93. https://doi.org/10.1016/j.jjcc.2018.02.011.[Elsevier Ltd:*2018-01-01]
Langiu A-LP-AMélanie, Crescence L et al (2022) Platelet and Cancer-Cell Interactions Modulate Cancer-Associated Thrombosis Risk in Different Cancer Types. CANCERS.;14(3):730. https://doi.org/10.3390/cancers140307302022/1/30]
Deeksha Khialani Sle, Cessie WM, Lijfering et al (2020) The joint effect of genetic risk factors and different types of combined oral contraceptives on venous thrombosis risk. BRIT J HAEMATOL 191(1):90–97. https://doi.org/10.1111/bjh.16666
Qianxi Feng E, Nickels IS, Muskens et al (2021) Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites. ELIFE 10. https://doi.org/10.7554/eLife.647932021/6/22]
Lee JM, Lee KM, Kim DB, Ko SH (2019) Park. Colorectal Cancer risks according to sex differences in patients with type II diabetes mellitus: A Korean nationwide Population-Based cohort study. CLIN TRANSL GASTROEN 10(10):e90. https://doi.org/10.14309/ctg.0000000000000090pmid:316514492019/10/1]
Ranpura V, Hapani S, Chuang J, Wu S.;49(3):287– 97. doi: 10.3109/02841860903524396 pmid:201561142010-04-01].
K., Vu NV, Luong J, Hubbard et al (2010) Risk of cardiac ischemia and arterial thromboembolic events with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis of randomized controlled trials. ACTA ONCOL. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center. CANCER MED-US 2015;4(1):27–35. doi: 10.1002/cam4.332 pmid:25487644.[(c) 2014 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.:*2015-01-01]
Brand JS, Hedayati E, Bhoo-Pathy N et al (2017) Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study. CANCER-AM CANCER SOC 123(3):468–475. https://doi.org/10.1002/cncr.30364pmid:27727456.[(c) 2016 American Cancer Society.:*2017-02-01]
Comments (0)